Form 4/A for CDNA CareDx, Inc.
Accepted 2024-04-09 00:00:00 ET · period of report 2024-02-01 · accession 0001217234-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-04-09 | 2024-02-01 | CDNA | Jain Abhishek | CFO | A - Grant | $0.00 | +174.5K | 293.6K | +147% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | A | A | 174,520 | $0.00 | 293,612 | D | — | — | (F2) The reported securities are represented by restricted stock units, 1/12th of which shall vest on May 1, 2024 and 1/12th of which shall vest on each date that is three months thereafter. (F1) This amendment is being filed to report the grant of restricted stock units which was inadvertently omitted from the original Form 4 filed on February 5, 2024. This resulted in an additional 174,520 shares deemed beneficially owned by the Reporting Person which were inadvertently omitted from the original Form 4. |